In the Liraglutide Effect and Action in Diabetes trial (LEAD-3), GLP-1RA liraglutide treatment significantly reduced body fat, but there was no significant change in lean body mass
Load management helps protect new tissue as it forms
Guidance for Supporting Clients Using GLP-1 Weight-Loss Medications
Your healthcare provider can submit a coverage request to Aetna requesting that they cover Ozempic as a weight loss treatment, but, in general, health insurance companies are less likely to cover off-label prescriptions
*Nutrition tables may vary by flavour, please read the product label to verify exact info
Higher doses of oral semaglutide (up to 50 mg/day) are under development for the treatment of both T2DM (104) and obesity (105), with effectiveness on par with 2.4 mg/week subcutaneous semaglutide approved for weight management